SpaceX vs Rocket Lab: As Investments
SpaceX (Nasdaq: SPCX) and Rocket Lab (Nasdaq: RKLB) are both publicly traded space companies, but they sit at opposite ends of the risk-and-scale spectrum — a freshly listed ~$2 trillion giant versus an established, still-scaling small-cap with a transformational acquisition in progress. This is a financial comparison, not a technical one; see our vehicle-and-operations comparison for the launch-vehicle side of the story.
| Metric | SpaceX (SPCX) | Rocket Lab (RKLB) |
|---|---|---|
| Ticker / Exchange | SPCX · Nasdaq | RKLB · Nasdaq |
| Listed Since | June 12, 2026 (IPO) | August 2021 (SPAC merger) |
| IPO / Debut Pricing | $135/share, priced at ~$1.78T; debut-day market cap ~$2.1T — largest IPO in history | N/A (SPAC, Vector Acquisition Corp) |
| Market Cap (Aug 2026) | ~$2T | ~$17B |
| Most Recent Quarterly Revenue | ~$15.5B (FY2025 run-rate, incl. Starlink) | $234M (Q2 2026, +62% YoY) |
| Revenue Mix | ~60% Starlink, ~40% launch services | Launch + space systems, moving toward global satcom post-Iridium |
| Backlog | $30B+ | $2.36B across 90+ contracted missions |
| Public Float / Liquidity | Limited — recently listed, still building trading history and analyst coverage | Established — 4+ years of public trading history, broad institutional ownership |
| Primary Growth Vehicle | Starship — first operational Starlink V3 mission flew Jul 24, 2026; cadence still ramping | Neutron — pad delivery targeted Q4 2026; first flight NET late 2026 (slipped from mid-2026) |
| Pending Corporate Action | None disclosed | Definitive agreement to acquire Iridium (IRDM) for ~$8B ($54/share cash-and-stock); expected to close mid-2027 |
| Profitability | Not disclosed publicly at per-segment level; overall business reported profitable pre-IPO | Approaching breakeven; Neutron development spend still pressures near-term margins |
| Key Bull Case | Starlink recurring revenue + Starship cost curve could make SpaceX the default heavy-lift and broadband provider for a generation | Neutron success + Iridium integration would transform RKLB from a launch company into a diversified space-systems and satcom operator |
| Key Bear Case | Priced for perfection at ~$2T; any Starship setback or Starlink competitive pressure (Kuiper) hits the thesis hard | Neutron has already slipped once; Iridium deal adds financing and integration risk ahead of a mid-2027 close |
Scale: A ~$2 Trillion Giant vs a Scaling Small-Cap
SpaceX went public on Nasdaq on June 12, 2026, pricing at $135/share for a ~$1.78 trillion valuation and closing its debut day around ~$2.1 trillion — the largest IPO in history. It has held roughly that level since, making it the single largest space-industry equity by an enormous margin. Rocket Lab, by contrast, has traded publicly since its 2021 SPAC merger and sits around a ~$17 billion market cap as of August 2026 — still a small-cap next to SpaceX, but up substantially on record quarterly revenue and the Iridium deal announcement.
That scale gap shapes everything else about the comparison. SpaceX is a mega-cap with a trading history measured in weeks; Rocket Lab is a small-cap with more than four years of quarterly reports, analyst coverage, and price history for investors to underwrite.
Revenue Mix and Growth
SpaceX's revenue run-rate is estimated above $15 billion annually, split roughly 60% Starlink subscription revenue and 40% launch services. That mix is what separates SpaceX from a pure launch company — Starlink is recurring, high-margin, and growing independent of launch cadence. The company also carries a launch and Starlink backlog north of $30 billion.
Rocket Lab posted record Q2 2026 revenue of $234 million, up 62% year-over-year, against a launch-and-space-systems backlog of $2.36 billion across more than 90 contracted missions. Growth is real and accelerating, but the company is still investing heavily in Neutron and is not yet consistently profitable — the opposite financial profile of SpaceX's reported pre-IPO profitability.
The Next 12 Months: Starship, Neutron, and Iridium
SpaceX's near-term catalyst is Starship's transition to routine operations — the vehicle flew its first operational payload mission, deploying Starlink V3 satellites, on Flight 13 (July 24, 2026), with cadence still ramping as tower-catch reliability improves. If Starship's launch cadence and reuse economics keep improving, it reinforces the bull case behind the ~$2T valuation. The risk is the flip side: any high-profile Starship setback, or faster-than-expected Kuiper/OneWeb competitive inroads against Starlink, would hit a stock priced for continued dominance.
Rocket Lab has two major catalysts running in parallel. Neutron — its medium-lift, partially reusable rocket — is targeting pad delivery in Q4 2026 with more than 400 Archimedes engine hot-fires completed, but first flight has already slipped from a mid-2026 target to no earlier than late 2026. Separately, Rocket Lab has a definitive agreement to acquire satellite operator Iridium Communications (Nasdaq: IRDM) for roughly $8 billion in cash and stock ($54/share), expected to close mid-2027. If both land, Rocket Lab becomes a fundamentally different company — launch provider, space-systems manufacturer, and global satcom operator in one. If either slips further or falls through, the stock likely gives back some of its 2026 re-rating.
How the Two Stocks Fit Different Portfolios
SPCX and RKLB aren't really substitutes for each other. SpaceX is a mega-cap bet on the entire space economy consolidating around one vertically integrated operator, priced accordingly. Rocket Lab is a smaller, higher-beta bet on execution risk paying off twice over — Neutron reaching orbit and the Iridium acquisition closing on schedule. Investors weighing space-sector exposure should treat this as a barbell, not a coin flip: SPCX for scale and Starlink's recurring-revenue moat, RKLB for a more leveraged, binary-catalyst play on the next 12-18 months.
Track live SPCX and RKLB prices alongside every other public space stock